Huib N. Caron

19.9k total citations · 4 hit papers
151 papers, 12.4k citations indexed

About

Huib N. Caron is a scholar working on Neurology, Molecular Biology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Huib N. Caron has authored 151 papers receiving a total of 12.4k indexed citations (citations by other indexed papers that have themselves been cited), including 69 papers in Neurology, 55 papers in Molecular Biology and 50 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Huib N. Caron's work include Neuroblastoma Research and Treatments (68 papers), Childhood Cancer Survivors' Quality of Life (48 papers) and Cancer, Hypoxia, and Metabolism (29 papers). Huib N. Caron is often cited by papers focused on Neuroblastoma Research and Treatments (68 papers), Childhood Cancer Survivors' Quality of Life (48 papers) and Cancer, Hypoxia, and Metabolism (29 papers). Huib N. Caron collaborates with scholars based in Netherlands, United States and Germany. Huib N. Caron's co-authors include André B. P. Kuilenburg, Albert H. Gennip, Stephan Kemp, Leontien C.M. Kremer, Rogier Versteeg, Elvira C van Dalen, Angelika Eggert, Peter van Sluis, Julie R. Park and Helena J. H. van der Pal and has published in prestigious journals such as Science, New England Journal of Medicine and Cell.

In The Last Decade

Huib N. Caron

149 papers receiving 12.2k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Histone deacetylases (HDACs): characterization of the classical HDAC family

2003 2.5k citations Albert H. Gennip, Huib N. Caron et al. profile →
Medical Assessment of Adverse Health Outcomes in Long-term Survivors of Childhood Cancer

2007 597 citations Leontien C.M. Kremer, Cor van den Bos et al. profile →
The Human Transcriptome Map: Clustering of Highly Expressed Genes in Chromosomal Domains

2001 571 citations Huib N. Caron, Frank Baas et al. profile →
Cardioprotective interventions for cancer patients receiving anthracyclines

2011 352 citations Elvira C van Dalen, Huib N. Caron et al. Cochrane Database of Systematic Reviews profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Huib N. Caron Netherlands	52	6.3k	3.1k	2.6k	2.5k	1.7k	151	12.4k
Towia A. Libermann United States	72	13.2k 2.1×	1.1k 0.3×	3.0k 1.2×	7.1k 2.9×	4.0k 2.3×	270	28.0k
Wendy B. London United States	69	7.1k 1.1×	12.0k 3.9×	1.6k 0.6×	3.9k 1.6×	4.9k 2.8×	276	17.4k
Mark W. Kieran United States	65	6.7k 1.1×	2.5k 0.8×	795 0.3×	2.7k 1.1×	2.7k 1.5×	268	14.9k
Wayne W. Grody United States	45	11.9k 1.9×	1.0k 0.3×	2.8k 1.1×	2.1k 0.8×	3.1k 1.8×	168	28.7k
Giuseppe Novelli Italy	61	8.1k 1.3×	894 0.3×	909 0.4×	765 0.3×	1.3k 0.8×	636	15.5k
David M. Thomas Australia	62	5.4k 0.9×	518 0.2×	971 0.4×	3.9k 1.6×	2.2k 1.3×	301	14.9k
Gregory H. Reaman United States	68	4.2k 0.7×	2.7k 0.9×	4.9k 1.9×	3.6k 1.5×	1.1k 0.6×	306	15.8k
R.J. Arceci United States	62	5.1k 0.8×	592 0.2×	1.3k 0.5×	3.5k 1.4×	1.0k 0.6×	390	12.5k
Phillip Görden United States	78	9.5k 1.5×	1.1k 0.3×	452 0.2×	1.8k 0.7×	1.1k 0.7×	286	20.2k
Diether Lambrechts Belgium	53	6.3k 1.0×	820 0.3×	400 0.2×	3.9k 1.6×	2.8k 1.6×	296	14.4k

Countries citing papers authored by Huib N. Caron

Since Specialization

Citations

This map shows the geographic impact of Huib N. Caron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huib N. Caron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huib N. Caron more than expected).

Fields of papers citing papers by Huib N. Caron

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Huib N. Caron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huib N. Caron. The network helps show where Huib N. Caron may publish in the future.

Co-authorship network of co-authors of Huib N. Caron

This figure shows the co-authorship network connecting the top 25 collaborators of Huib N. Caron. A scholar is included among the top collaborators of Huib N. Caron based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huib N. Caron. Huib N. Caron is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Eleveld, Thomas F., Linda Schild, Lindy K. Alles, et al.. (2023). MEK inhibition causes BIM stabilization and increased sensitivity to BCL-2 family member inhibitors in RAS-MAPK-mutated neuroblastoma. Frontiers in Oncology. 13. 1130034–1130034. 6 indexed citations

Vassal, Gilles, Peter J. Houghton, Stefan M. Pfister, et al.. (2021). International Consensus on Minimum Preclinical Testing Requirements for the Development of Innovative Therapies For Children and Adolescents with Cancer. Molecular Cancer Therapeutics. 20(8). 1462–1468. 16 indexed citations

Kraal, Kathelijne C.J.M., Ilse Timmerman, Cor van den Bos, et al.. (2018). Peripheral Stem Cell Apheresis is Feasible Post 131Iodine-Metaiodobenzylguanidine-Therapy in High-Risk Neuroblastoma, but Results in Delayed Platelet Reconstitution. Clinical Cancer Research. 25(3). 1012–1021. 5 indexed citations

Sieswerda, Elske, Anna Font‐Gonzalez, Johannes B. Reitsma, et al.. (2016). High Hospitalization Rates in Survivors of Childhood Cancer: A Longitudinal Follow-Up Study Using Medical Record Linkage. PLoS ONE. 11(7). e0159518–e0159518. 21 indexed citations

Dolman, M. Emmy M., Evon Poon, Marli E. Ebus, et al.. (2015). Cyclin-Dependent Kinase Inhibitor AT7519 as a Potential Drug for MYCN-Dependent Neuroblastoma. Clinical Cancer Research. 21(22). 5100–5109. 47 indexed citations

Nicolaas, Simone M. Sint, Sasja A. Schepers, Peter M. Hoogerbrugge, et al.. (2015). Screening for Psychosocial Risk in Dutch Families of a Child With Cancer: Reliability, Validity, and Usability of the Psychosocial Assessment Tool. Journal of Pediatric Psychology. 41(7). 810–819. 20 indexed citations

Mulder, Renée L., Sebastiaan L. Knijnenburg, Ronald B. Geskus, et al.. (2013). Glomerular Function Time Trends in Long-Term Survivors of Childhood Cancer: A Longitudinal Study. Cancer Epidemiology Biomarkers & Prevention. 22(10). 1736–1746. 36 indexed citations

Schoot, Reineke A., et al.. (2013). The role of 131I-metaiodobenzylguanidine (MIBG) therapy in unresectable and compromising localised neuroblastoma. European Journal of Nuclear Medicine and Molecular Imaging. 40(10). 1516–1522. 7 indexed citations

Sieswerda, Elske, Elvira C van Dalen, A. Postma, et al.. (2012). Cochrane Review: Medical interventions for treating anthracycline‐induced symptomatic and asymptomatic cardiotoxicity during and after treatment for childhood cancer. Evidence-Based Child Health A Cochrane Review Journal. 7(6). 1857–1902. 1 indexed citations

10.

Mulder, Renée L., Elvira C van Dalen, Edith Leclercq, et al.. (2011). Hepatic late adverse effects after antineoplastic treatment for childhood cancer. Cochrane Database of Systematic Reviews. 4(7). CD008205–CD008205. 33 indexed citations

11.

Stutterheim, Janine, et al.. (2011). Methylated RASSF1a Is the First Specific DNA Marker for Minimal Residual Disease Testing in Neuroblastoma. Clinical Cancer Research. 18(3). 808–814. 28 indexed citations

12.

Tytgat, Godelieve A.M., Rutger Meinsma, René Leen, et al.. (2011). Synergistic interaction between cisplatin and gemcitabine in neuroblastoma cell lines and multicellular tumor spheroids. Cancer Letters. 319(1). 23–30. 32 indexed citations

13.

Kuilenburg, André B. P., et al.. (2011). Promising effects of the 4HPR–BSO combination in neuroblastoma monolayers and spheroids. Free Radical Biology and Medicine. 51(6). 1213–1220. 9 indexed citations

14.

Brouwer, Nannette, F.N.J. Frakking, Marianne D. van de Wetering, et al.. (2009). Mannose-Binding Lectin (MBL) Substitution: Recovery of Opsonic Function In Vivo Lags behind MBL Serum Levels. The Journal of Immunology. 183(5). 3496–3504. 29 indexed citations

15.

Hasselt, Nancy E., Dirk Troost, Huib N. Caron, et al.. (2008). Molecular Risk Stratification of Medulloblastoma Patients Based on Immunohistochemical Analysis of MYC, LDHB, and CCNB1 Expression. Clinical Cancer Research. 14(13). 4154–4160. 41 indexed citations

16.

Tytgat, Godelieve A.M., René Leen, Pedro Brites, et al.. (2008). Pleiotropic effects of fenretinide in neuroblastoma cell lines and multicellular tumor spheroids. International Journal of Oncology. 32(5). 1011–9. 19 indexed citations

17.

Kraker, Jan de, et al.. (2008). Iodine-131-metaiodobenzylguanidine as initial induction therapy in stage 4 neuroblastoma patients over 1 year of age. European Journal of Cancer. 44(4). 551–556. 87 indexed citations

18.

Bierau, Jörgen, Albert H. Gennip, René Leen, et al.. (2005). Cyclopentenyl cytosine-induced activation of deoxycytidine kinase increases gemcitabine anabolism and cytotoxicity in neuroblastoma. Cancer Chemotherapy and Pharmacology. 57(1). 105–113. 21 indexed citations

19.

Freling, Nicole, L.E.C.M. Blank, Alfons J. M. Balm, et al.. (2005). Amore protocol in pediatric head and neck rhabdomyosarcoma: Descriptive analysis of failure patterns. Head & Neck. 27(5). 390–396. 20 indexed citations

20.

Molenaar, Jan J., Peter van Sluis, Kathy Boon, Rogier Versteeg, & Huib N. Caron. (2003). Rearrangements and increased expression of cyclin D1 (CCND1) in neuroblastoma. Genes Chromosomes and Cancer. 36(3). 242–249. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact